Contributions of the molecular biologist in gastrointestinal cancer and precancer screening. Current possibilities and future prospects

Gastrointestinal Endoscopy Clinics of North America

Volumn 7, Issue 1, 1997, Pages 147-164

  Craanen, M E ^a   Offerhaus, J A ^a   Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER SCREENING; COLON POLYPOSIS; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DNA CONTENT; FAMILIAL CANCER; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MUTATION; ONCOGENE; PANCREAS CARCINOMA; PRECANCER; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 0031050670     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1052-5157(18)30329-5     Document Type: Review

References (142)

1. Aaltonen L.A. Peltomaki P. Leach F.S. Clues to the pathogenesis of familial colorectal cancer Science 260 1993 812
2. Albano W.A. Recebaren J.A. Lynch H.T. Natural history of hereditary cancer of the breast and colon Cancer 50 1982 360
3. Almoguera C. Shibata D. Forrester K. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549
4. Altorki N.K. Sunagawa M. Little A.G. High-grade dysplasia in the columnar-lined esophagus Am J Surg 161 1991 97
5. Axon A.T.R. Colonic cancer surveillance in ulcerative colitis is not essential for every patient Eur J Cancer 31A 1995 1183
6. Bargen T.A. Chronic ulcerative colitis associated with malignant disease Arch Surg 17 1928 862
7. Battifora H. p53 Immunohistochemistry: A word of caution Hum Pathol 25 1994 435
8. Berenson M.M. Riddell R.H. Skinner D.B. Malignant transformation of oesophageal columnar epithelium Cancer 41 1978 554
9. Blount P.L. Meitzer S.J. Yin J. Clonal ordering of 17p and 5q allelic losses in Barrett’s dysplasia and adenocarcinoma Proc Natl Acad Sei U S A 90 1993 3221
10. Borrie J. Goldwater L. Columnar cell-lined esophagus: Assessment of etiology and treatment. A 22 year experience J Thorac Cardiovasc Surg 71 1976 825
11. Bos J.L. The ras gene family and human carcinogenesis Mutat Res 195 1988 255
12. Bremner C.G. Columnar-lined oesophagus. Support for the acquired theory in a patient with adenocarcinoma J R Coll Surg Edinb 20 1975 266
13. Bremner C.G. Hamilton D.G. Barrett’s esophagus. Controversial aspects DeMeester T.R. Skinner D.B. Esophageal Disorders: Pathophysiology and Therapy 1985 Raven New York 233
14. Brentnall T.A. Haggitt R.C. Rabinovitch P.S. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis Gastroenterology 110 1996 331
15. Bronner C.E. Baker S.M. Morrison P.T. Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer Nature 368 1994 258
16. Burmer G.C. Levine D.S. Kulander B.G. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma Gastroenterology 99 1990 416
17. Burmer G.C. Rabinovitch P.S. Haggitt R.C. Neoplastic progression in ulcerative colitis: Histology, DNA content and loss of p53 allele Gastroenterology 103 1992 1602
18. Cameron A.J. Ott B.J. Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus N Engl J Med 313 1985 857
19. Cameron A.J. Zinsmeister A.R. Ballard D.J. Prevalence of columnar-lined (Barrett’s) esophagus: Comparison of population-based and autopsy findings Gastroenterology 99 1990 918
20. Caygill C.P.J. Hill M.J. Kirkham J.S. Mortality from gastric cancer following gastric surgery for peptic ulcer Lancet 1 1986 929
21. Chaubert P. Benhattar J. Saraga E. K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis Am J Pathol 144 1994 767
22. Chen J. Compton C. Cheng B. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis Gastroenterology 102 1992 1983
23. Cho K.R. Fearon E.R. DCC: Linking tumour suppressor genes and altered cell surface interactions in cancer? Eur J Cancer 31A 1995 1055
24. Chowdary D.R. Dermody J.J. Jha K.K. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway Mol Cell Biol 14 1994 1997
25. Debinski H.S. Spigelman A.D. Hatfield A. Upper intestinal surveillance in familial adenomatous polyposis Eur J Cancer 31A 1995 1149
26. Dent J. Bremner C.G. Collen M.J. Working party report to the World Congresses of Gastroenterology, Sydney, 1990: Barrett’s esophagus J Gastroenterol Hepatol 6 1991 1
27. Devroede C.J. Taylor W.F. Sauer W.G. Cancer risk and life expectancy of children with ulcerative colitis N Engl J Med 285 1971 17
28. Ekbom A. Helminck C. Zack M. Ulcerative colitis and colorectal cancer: A population-based study N Engl J Med 323 1990 1228
29. El-Deiry W.S. Tokino T. Velculescu V.E. WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817
30. Fennerty M.B. Sampliner R.E. Way D. Discordance between flow cytometric abnormalities and dysplasia in Barrett’s esophagus Gastroenterology 97 1989 815
31. Fishel R. Ewel A. Less S. Binding of mismatched microsatellite DNA sequences by the human MSH2 protein Science 266 1994 1403
32. Fishel R. Lescoe M.K. Rao M.R.S. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer Cell 75 1993 1027
33. Freedman D. Waxman I. Biology of pancreatic cancer Rustgi A.K. Gastrointestinal Cancers: Biology, Diagnosis, and Therapy 1995 Lippincott-Raven Philadelphia 315
34. Garewal H.S. Sampliner R.E. Liu Y. Chromosomal rearrangements in Barrett’s esophagus—a premalignant lesion of esophageal adenocarcinoma Cancer Genet Cytogenet 42 1989 281
35. Gottfried M.R. McClave S.A. Boyce H.W. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett’s esophagus) Am J Clin Pathol 92 1989 741
36. Gray M.R. Hall P.A. Nash J. Epithelial cell proliferation in Barrett’s esophagus by proliferating cell nuclear antigen immunolocalization Gastroenterology 103 1992 1769
37. Greenwald B.D. Harpaz N. Yin J. Loss of heterozygosity affecting the p53, Rb, and mcc/ape tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis Cancer Res 52 1992 741
38. Grilley M. Welsh K.M. Su S. Isolation and characterization of the Esherichia coli mutL gene product J Biol Chem 264 1989 1000
39. Haggitt R.C. Adenocarcinoma in Barrett’s esophagus: A new epidemic? Hum Pathol 23 1992 475
40. Haggitt R.C. Neoplastic progression in Barrett’s esophagus Hum Pathol 25 1994 982
41. Haggitt R.C. Dean P.J. Adenocarcinoma in Barrett’s epithelium Spechler S.J. Goyal R. Barrett’s Esophagus: Pathophysiology, Diagnosis, and Management 1985 Elseviers New York 53
42. Haggitt R.C. Tryzelaar J. Ellis F.H. Adenocarcinoma complicating columnar epithelial lined (Barrett’s) esophagus Am J Clin Pathol 70 1978 1
43. Hall P.A. Lane D.P. p53 In tumour pathology: Can we trust immunohistochemistry?—revisited J Pathol 172 1994 1
44. Hameeteman W. Tytgat G.N.J. Houthoff H.J. Barrett’s esophagus: Development of dysplasia and adenocarcinoma Gastroenterology 96 1989 1249
45. Hamelin R. Flejou J.F. Muzeau F. TP53 gene mutations and p53 immunoreactivity in malignant and premalignant Barrett’s esophagus Gastroenterology 107 1992 1012
46. Hamilton S.R. Smith R.R.L. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus Am J Clin Pathol 87 1987 301
47. Hamilton S.R. Smith R.R.L. Cameron J.L. Prevalence and characteristics of Barrett’s esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction Hum Pathol 19 1988 942
48. Hawe A. Payne W.S. Weiland L.H. Adenocarcinoma in the columnar-lined lower (Barrett’s) esophagus Thorax 28 1973 511
49. Herbst J.J. Berenson M.M. McCloskey D.W. Cell proliferation in esophageal columnar epithelium (Barrett’s esophagus) Gastroenterology 75 1978 683
50. Iguchi H. Sugano K. Fukayama N. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer Gastroenterology 110 1996 221
51. Ionov Y. Peinado M.A. Malkhosyan S. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis Nature 363 1993 558
52. Jankowski J. Coghill G. Hopwood D. Oncogenes and oncosuppressor genes in adenocarcinomas of the oesophagus Gut 33 1992 1033
53. Jankowski J. Hopwood D. Wormsley K.G. Flow-cytometric analysis of growth regulatory peptides and their receptors in Barrett’s oesophagus and oesophageal adenocarcinoma Scand J Gastroenterol 27 1992 147
54. Jankowski J. McMenemin R. Hopwood D. Abnormal expression of growth regulatory factors in Barrett’s esophagus Clin Sei 81 1991 663
55. Kee F. Collins B.J. How prevalent is cancer family syndrome? Gut 32 1991 509
56. Kern S.E. Redston M. Seymour A.B. Molecular genetic profiles of colitis-associated neoplasms Gastroenterology 107 1994 420
57. Kondo H. Sugano K. Fukayama N. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma Cancer 73 1994 1589
58. Krishnadath K.K. Tilanus H.W. Alers J.C. Detection of genetic changes in Barrett’s adenocarcinoma and Barrett’s esophagus by DNA in situ hybridization and immunohistochemistry Cytometry 15 1994 176
59. Kunkel T.A. Slippery DNA and diseases Nature 365 1993 207
60. Leach F.S. Nicolaides N.C. Papadopoulos N. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer Cell 75 1993 1215
61. Lennard-Jones J.E. Melville D.M. Morson B.C. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years Gut 31 1990 800
62. Levinson G. Gutman G.A. High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12 Nucleic Acids Res 15 1987 5323
63. Losi L. Benhattar J. Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer Eur J Cancer 28A 1992 1115
64. Lothe R.A. Peltomaki P. Meling G.I. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history Cancer Res 53 1993 5849
65. Lynch D.A.F. Lobo A.J. Sobala G.M. Failure of colonoscopic surveillance in ulcerative colitis Gut 34 1993 1075
66. Lynch H.T. Smyrk T. Lynch J. Update on the differential diagnosis, surveillance and management of hereditary non polyposis colorectal cancer Eur J Cancer 31A 1995 1039
67. Lynch H.T. Smyrk T.C. Watson P. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review Gastroenterology 104 1993 1535
68. Lynch H.T. Watson P. Lanspa S.J. Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndomes I and II) Dis Colon Rectum 31 1988 439
69. Macrae F.A. Faecal occult blood testing: Sensitivity and specificity Br J Surg 72 1985 S67
70. McArdle J.E. Lewin K.J. Randall G. Distribution of dysplasias and early invasive carcinoma in Barrett’s esophagus Hum Pathol 23 1992 479
71. McKinley M.J. Budman D.R. Grueneberg D. DNA content in Barrett’s esophagus and esophageal malignancies Am J Gastroenterol 82 1987 1012
72. Mecklin J.-P. Jarvinen H.J. Clinical features of colorectal carcinoma in cancer family syndrome Dis Colon Rectum 29 1986 160
73. Mecklin J.-P. Jarvinen H.J. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer) Cancer 68 1991 1109
74. Meitzer S.J. Mane S.M. Wood P.K. Activation of c-Ki-ras in gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products Cancer Res 50 1990 3627
75. Menguy R. On the malignant potential of the acquired short esophagus Arch Surg 114 1978 260
76. Messian R.A. Hermos J.A. Robbins A.H. Barrett’s esophagus. Clinical review of 26 cases Am J Gastroenterol 69 1978 458
77. Miros M. Kerline P. Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus Gut 32 1991 1441
78. Modrich P. Mechanisms and biological effects of mismatch repair Annu Rev Genet 25 1991 229
79. Modrich P. Methyl-directed DNA mismatch repair J Biol Chem 264 1989 6597
80. Monnier P.H. Fontolliet C. Savary M. Barrett’s oesophagus or columnar epithelium of the lower oesophagus Baillieres Clin Gastroenterol 1 1987 767
81. Naef A.P. Savary M. Ozzello L. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition J Thorac Cardiovasc Surg 70 1975 826
82. Nakaizumi A. Tatsuta M. Vehara H. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma Cancer 70 1992 2610
83. Nicolaides N.C. Papadopoulos N. Liu B. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer Nature 371 1994 75
84. Niederau C. Grendell J.H. Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers Pancreas 7 1992 66
85. Offerhaus G.J.A. van de Stadt J. Huibregtse K. The mucosa of the gastric remnant harboring malignancy Cancer 64 1989 698
86. Papadopoulos N. Nicolaides N.C. Wei Y.-F. Mutation of a mutL homolog in hereditary colon cancer Science 263 1994 1625
87. Peddanna N. Holt S. Verma R.S. Genetics of gastric cancer Anticancer Res 15 1995 2055
88. Powell S. Papadopoulos N. Kinzler K.W. Truncating APC gene mutations in the mutation cluster region are rare in esophageal cancers Gastroenterology 107 1994 1759
89. Press M.F. Hung G. Godolphin W. Slamon D.J. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression Cancer Res 54 1994 2771
90. Provenzale D. Endoscopic technology assessment in the 1990s: The role of decision analysis Cotton P.B. Tytgat G.N.J. Williams C.B. Annual of Gastrointestinal Endoscopy ed 8 1995 Current Science London 1
91. Provenzale D. Kemp J.A. Arora S. A guide for surveillance of patients with Barrett’s esophagus Am J Gastroenterol 89 1994 670
92. Pulciani S. Santos E. Long L.K. Ras gene amplification and malignant transformation Mol Cell Biol 5 1985 2836
93. Radigan L.R. Glover J.L. Shipley F.E. Barrett esophagus Arch Surg 112 1977 486
94. Ramel S. Reid B.J. Sanchez C.A. Evaluation of p53 protein expression in Barrett’s esophagus by two-parameter flow cytometry Gastroenterology 102 1992 1220
95. Ransom J.M. Patel G.K. Clift S.A. Extended and limited types of Barrett’s esophagus in the adult Ann Thorac Surg 33 1982 19
96. Raskind W.H. Norwood T. Levine D.S. Persistent clonal areas and clonal expansion in Barrett’s esophagus Cancer Res 52 1992 2946
97. Reid B.J. Blount P.L. Rubin C.E. Predictors of progression to malignancy in Barrett’s esophagus: Endoscopic, histologic and flow cytometric follow-up of a cohort Gastroenterology 102 1992 1212
98. Reid B.J. Haggitt R.C. Rubin C.E. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus Hum Pathol 19 1988 166
99. Reid B.J. Rubin C.E. When is the columnar-lined esophagus premalignant? Gastroenterology 88 1985 1552
100. Reid B.J. Sanchez C.A. Blount P.L. Barrett’s esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression Gastroenterology 105 1993 119
101. Reid B.J. Weinstein W.M. Lewin K.J. Endoscopic biopsy can detect early adenocarcinoma in Barrett’s esophagus without grossly recognizable neoplastic lesions Gastroenterology 94 1988 81
102. Rice T.W. Falk G.W. Achkar E. Surgical management of high-grade dysplasia in Barrett’s esophagus Am J Gastroenterol 88 1993 1832
103. Riddell R.H. Goldman H. Ransohoff D.F. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications Hum Pathol 14 1983 931
104. Robertson C.S. Mayberry J.F. Nicholson D.A. Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s oesophagus Br J Surg 75 1988 760
105. Rosenstock E. Farmer R.G. Petras R. Surveillance for colonic carcinoma in ulcerative colitis Gastroenterology 89 1985 1342
106. Sampliner R.E. High grade dysplasia in Barrett’s esophagus: An evolving clinical dilemma Am J Gastroenterol 88 1993 1811
107. Shibata D. Capella G. Perucho M. Mutational activation of the c-K-ras gene in human pancreatic carcinoma Baillieres Clin Gastroenterol 4 1990 151
108. Sidransky D. Tokino T. Hamilton S.R. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumor Science 256 1992 102
109. Sigal I.S. The ras oncogene: A structure and some function Nature 332 1988 485
110. Simon J.B. Occult blood screening for colorectal carcinoma: A critical review Gastroenterology 88 1985 820
111. Skinner D.B. Walther B.C. Riddell R.H. Barrett’s esophagus. Comparison of benign and malignant cases Ann Surg 198 1983 554
112. Smith-Raven J. England J. Talbot I.C. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients Gut 36 1995 81
113. Spechler S.J. Barrett’s esophagus: What’s new and what to do? Am J Gastroenterol 84 1989 220
114. Spechler S.J. Endoscopic surveillance for patients with Barrett’s esophagus: Prevalence and incidence of adenocarcinoma Ann Intern Med 106 1987 902
115. Spechler S.J. Goyal R.K. Barrett’s esophagus N Engl J Med 315 1986 362
116. Spechler S.J. Robbins A.A. Rubins H.B. Adenocarcinoma and Barrett’s esophagus: An overrated risk? Gastroenterology 87 1987 927
117. Strand M. Prolla T.A. Liskay R.M. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair Nature 365 1993 274
118. Su S.S. Modrich P. Escherichia coli mutS-encoded protein binds to mismatched base pairs Proc Natl Acad Sei U S A 53 1986 5057
119. Tada M. Ohashi M. Shiratori Y. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease Gastroenterology 110 1996 227
120. Thibodeau S.N. Bren G. Schaid D. Microsatellite instability in cancer of the proximal colon Science 260 1993 816
121. Thompson J.J. Zinsser K.R. Enterline H.T. Barrett’s metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction Hum Pathol 14 1983 42
122. Tobi M. Luo F.C. Ronai Z. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma J Natl Cancer Inst 86 1994 1007
123. Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation Ann Surg 210 1989 159
124. Unger C. Kress S. Buchmann A. y—Irradiation-induced micronuclei from mouse hepatoma cells accumulate high levels of the tumor suppressor protein p53 Cancer Res 54 1994 3651
125. Van Es J.M. Polak M.M. van den Berg F.M. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: Mutation of K-ras and overexpression of p53 protein product J Clin Pathol 48 1995 218
126. Van Laethem J.-L. Vertongen P. Deviere J. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours Gut 36 1995 781
127. Vasen H.F.A. den Hartog F.C.A. Menko F.H. Screening for hereditary nonpolyposis colorectal cancer: a study of 22 kindreds in the Netherlands Am J Med 86 1989 278
128. Vasen H.F.A. Mecklin J.-P. Meera Khan P. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC) Dis Colon Rectum 34 1991 424
129. Vasen H.F.A. Offerhaus G.J.A. den Hartog Jager F.C.A. The tumour spectrum in hereditary nonpolyposis colorectal cancer: A study of 24 kindreds in the Netherlands Int J Cancer 46 1990 31
130. Vasen H.F.A. Wijnen J.T. Menko F. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis Gastroenterology 110 1996 1020
131. Venu R.P. Geenen J.E. Kini M. Endoscopic retrograde brush cytology: A new technique Gastroenterology 99 1990 1475
132. Vogelstein B. Fearon E.R. Hamilton S.R. Genetic alterations during colorectal tumor development N Engl J Med 319 1989 525
133. Vogelstein B. Kinzler K.W. p53 Function and dysfunction Cell 70 1992 523
134. Watson P. Lynch H.T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer Utsunomiya J. Lynch H.T. Hereditary Coloretal Cancer 1990 Springer Verlag Tokyo 119
135. Welsh K.M. Lu A.-L. Clark S. Isolation and characterization of the Escherichia coli mutH gene product J Biol Chem 262 1987 15624
136. Winters C. Spurling T.J. Chobanian S.J. Barrett’s esophagus: A prevalent occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118
137. Woolf G.M. Riddell R.H. Irvine E.J. A study to examine agreement between endoscopy and histology for the diagnosis of columnar-lined (Barrett’s) esophagus Gastrointest Endosc 35 1989 541
138. Woolrich A.J. DaSilva M.D. Korelitz B.I. Surveillance in the routine management of ulcerative colitis: The predictable value low grade dysplasia Gastroenterology 103 1992 431
139. Wynford-Thomas D. p53 in tumour pathology: Can we trust immunohistochemistry? J Pathol 166 1992 329
140. Xia L. Shen W. Ritacca F. A truncated hMSH2 transcript occurs as a common variant in the population: Implications for genetic diagnosis Cancer Res 56 1996 2289
141. Yin J. Harpaz N. Tong Y. p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions Gastroenterology 104 1993 1633
142. Younes M. Lebovitz R.M. Lechago L.V. p53 Protein accumulation in Barrett’s metaplasia, dysplasia, and carcinoma: A follow-up study Gastroenterology 105 1993 1637